Brennan Daniel J.
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1595612. Latest Form 4 filed Oct 22, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc / MaVRTX | Director | 1 | 2026-10-20 | 2026-10-20 |
Transactions: 1
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-20 | Vertex Pharmaceuticals Inc / MaDirector | Grant or award | 795 | $503.47 | $400.3k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.